FLACS vs Phaco in Shallow Anterior Chamber
Launched by ILADEVI CATARACT AND IOL RESEARCH CENTER · Jul 3, 2018
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
Inclusion Criteria:
* Age-related cataract
* Shallow Anterior Chamber (\<2.5mm)
Exclusion Criteria:
-Ocular co-morbidity - corneal disorders, glaucoma, uveitis, previous ocular surgery
Surgical Technique :
* Standardized, Single Surgeon
* 2.2 mm clear corneal temporal incision
* FLACS Group : Capsulorhexis, Lens Fragmentation with femto laser
The investigators will be evaluating the following parameters:
1. Primary outcome measure Corneal thickness on day 1, week 1 and 1 month (Change in corneal thickness of 15% from preop. will be considered significant).
2. Secondary outcome measur...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • uncomplicated, age related cataracts
- • Shallow anterior chamber (measured as \</=2.5mm )
- Exclusion Criteria:
- • Coexisting ocular morbidity,
- • inability to come for followup
About Iladevi Cataract And Iol Research Center
Iladevi Cataract and IOL Research Center is a leading clinical research facility dedicated to advancing ophthalmic science, particularly in the fields of cataract surgery and intraocular lens (IOL) technology. With a commitment to innovative research and patient-centered care, the center collaborates with renowned ophthalmologists and researchers to conduct rigorous clinical trials aimed at improving surgical outcomes and enhancing patient quality of life. By leveraging state-of-the-art technology and adhering to the highest ethical standards, Iladevi strives to contribute to the global body of knowledge in ophthalmology and drive the development of cutting-edge solutions for vision restoration.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ahmedabad, Gujarat, India
Patients applied
Trial Officials
Abhay Vasavada, MS,FRCS
Principal Investigator
Iladevi Cataract & IOL Research Centre, Ahmedabad
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials